Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The spindle checkpoint monitors the fidelity of chromosome separation during mitosis. Aberrations in key regulators of this process have been found in human malignancies associated with chromosomal instability (CIN). Important chemotherapeutic agents which alter microtubule dynamics such as paclitaxel and vincristine, prolong spindle checkpoint activation and delay the completion of mitosis. Intriguingly, inhibition of BubR1 or overexpression of Aurora kinase A, spindle checkpoint regulators implicated in CIN, promote resistance to microtubule inhibitors (MTIs) in vitro. Taxanes have failed to demonstrate significant clinical benefit in phase II trials in colorectal cancer (CRC). The high incidence of CIN in this disease, coupled with alterations in spindle checkpoint regulators in vivo, may explain the disappointing results associated with taxane based therapies for CRC. A phase II trial of taxanes in patients with metastatic CIN negative CRC may be indicated.

Original publication

DOI

10.4161/cc.5.8.2682

Type

Journal article

Journal

Cell Cycle

Publication Date

04/2006

Volume

5

Pages

818 - 823

Keywords

Antineoplastic Agents, Aurora Kinase A, Aurora Kinases, Chromosomal Instability, Clinical Trials as Topic, Colorectal Neoplasms, Drug Resistance, Neoplasm, Humans, Microtubules, Mitosis, Neoplasm Metastasis, Paclitaxel, Protein Kinases, Protein-Serine-Threonine Kinases, Spindle Apparatus, Taxoids, Vincristine